SCICLONE PHARMACEUTICALS
SciClone Pharmaceuticals, Inc. (SciClone ) is a global specialty pharmaceutical company. It has a product portfolio of therapies for cancer and infectious diseases. SciClone has in-licensed two products that are part of this international commercial growth strategy, DC Bead and ondansetron RapidFilm. Its DC Bead product candidate is a treatment for liver cancer, which is approved in 40 countries worldwide, including Europe and the United States. Ondansetron RapidFilm is an oral thin film formula... tion of ondansetron used to treat and prevent nausea and vomiting caused by chemotherapy, radiotherapy and surgery. SCV-07 is being developed for the delay of onset of severe oral mucositis in patients receiving chemoradiation therapy for the treatment of cancers of the head and neck and for the treatment of hepatitis C virus (HCV). Thymalfasin is being developed in an ongoing clinical trial for improvement of Influenza A (H1N1) vaccination.
SCICLONE PHARMACEUTICALS
Industry:
Biotechnology Health Care
Founded:
1990-01-01
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.sciclone.com
Total Employee:
501+
Status:
Active
Contact:
(650) 358-3456
Email Addresses:
[email protected]
Total Funding:
134 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Euro AJAX Libraries API ASP.NET IIS Sectigo SSL Sectigo Domain SSL ASP.NET 4.0
Similar Organizations
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
ZWI Therapeutics, Inc.
ZWI Therapeutics is a biotech company developing a new polymer to reduce immunogenicity and aid pharmacokinetics of protein therapeutics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2011-04-19 | NovaMed Pharmaceuticals | NovaMed Pharmaceuticals acquired by SciClone Pharmaceuticals | 105 M USD |
Investors List
Opportunity Fund
Opportunity Fund investment in Venture Round - SciClone Pharmaceuticals
Shanghai Pharmaceutical
Shanghai Pharmaceutical investment in Venture Round - SciClone Pharmaceuticals
IDG Capital
IDG Capital investment in Venture Round - SciClone Pharmaceuticals
Grand View Capital
Grand View Capital investment in Venture Round - SciClone Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-12-28 | Ability Pharmaceuticals | SciClone Pharmaceuticals investment in Corporate Round - Ability Pharmaceuticals | 3 M USD |
Official Site Inspections
http://www.sciclone.com Semrush global rank: 3.38 M Semrush visits lastest month: 4.65 K
- Host name: 113-28-176-121.static.imsbiz.com
- IP address: 113.28.176.121
- Location: Central Hong Kong
- Latitude: 22.2909
- Longitude: 114.15
- Timezone: Asia/Hong_Kong
More informations about "SciClone Pharmaceuticals"
SciClone Pharmaceuticals - Crunchbase Company …
SciClone Pharmaceuticals, Inc. (SciClone ) is a global specialty pharmaceutical company. It has a product portfolio of therapies for cancer and infectious diseases. SciClone has in-licensed two products that are part of this …See details»
赛生药业控股有限公司 SciClone Pharmaceuticals …
赛生药业,SciClone,赛生药业控股有限公司,SciClone Pharmaceuticals (Holdings) LimitedSee details»
SciClone Pharmaceuticals Inc - Company Profile and News
SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company acquires, develops, and commercializes drugs for treating chronic and life-threatening diseases such as …See details»
SciClone Pharmaceuticals - Overview, News & Similar companies ...
Feb 11, 2019 View SciClone Pharmaceuticals (www.sciclone.com) location in Shanghai, China , revenue, industry and description. Find related and similar companies as well as employees …See details»
SciClone Pharmaceuticals - Funding, Financials, Valuation
SciClone Pharmaceuticals is registered under the ticker HKG:6600 . Their stock opened with HK$18.80 in its Mar 3, 2021 IPO. SciClone Pharmaceuticals is funded by 4 investors. …See details»
SciClone Pharmaceuticals Company Profile - Office Locations ...
SciClone is a global specialty pharmaceutical company with products in oncology, infectious diseases and cardiovascular disorders. Learn about its revenue, net income, cash, EBIT, …See details»
SciClone Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. SciClone Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Number of …See details»
赛生药业控股有限公司 SciClone Pharmaceuticals (Holdings) Limited
CRE has become a public health threat worldwide, which the World Health Organization has listed as one of the three critical pathogens in need of new antimicrobial options. The incidence of …See details»
SciClone Enters Into Definitive Merger Agreement To …
Jun 8, 2017 SciClone Pharmaceuticals, a US-based specialty pharmaceutical company with a substantial business in China, has entered into a merger agreement with a consortium of entities affiliated with GL ...See details»
Consortium Led By GL Capital Completes Acquisition …
FOSTER CITY, Calif., Oct. 13, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) (the "Company" or "SciClone") and a consortium consisting of entities affiliated with GL Capital ...See details»
Kirkland Represents GL Capital on Proposed Privatization of …
Mar 28, 2024 SciClone Pharmaceuticals is principally engaged in developing and commercializing a portfolio of marketed products and pipeline with potential in its focused …See details»
Menarini Group and SciClone Pharmaceuticals Announce Exclusive …
Nov 7, 2023 SciClone and Menarini have entered into an exclusive sub-licensing agreement to develop and commercialize ORSERDU® (elacestrant), a new oral endocrine therapy for ER+, …See details»
Menarini Group and SciClone Pharmaceuticals Announce
Nov 7, 2023 Staying true to the Group's original aspiration of "SciClone gives life hope", SciClone is dedicated to improving patients' health by providing top-tier healthcare products …See details»
SciClone Gains Support for Privatization Plan - Nasdaq
May 29, 2024 SciClone Pharmaceuticals (Holdings) Limited, in collaboration with Silver Pegasus Investment Limited, announced a non-binding letter of support from Pentwater Capital …See details»
The Chinese pharmaceutical company SciClone joins the capital of ...
Dec 28, 2020 The Catalan biopharmaceutical successfully closes a crowdfunding campaign with Capital Cell by raising 2 million € in one month; In 2020 the company has raised 12.4 million €See details»
Working at SciClone Pharmaceuticals - Zippia
Learn about working at SciClone Pharmaceuticals from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more. ... Organization Type. …See details»
Sciclone Pharmaceuticals Inc. - The New York Times
Apr 25, 1994 Shares of Sciclone dropped $7.5625, or 59 percent, closing at $5.1875 in heavy Nasdaq trading. The company has exclusive rights to sell thymosin, a new drug for chronic …See details»
SciClone: Inferring Clonal Architecture and Tracking the Spatial …
We demonstrate SciClone by inferring low-frequency subclones from a single MM sample and by quantitatively assessing the clonality of driver mutations in (potentially noisy) WES-derived …See details»
SciClone: Inferring Clonal Architecture and Tracking the Spatial …
Aug 7, 2014 SciClone has already contributed to the understanding of biological mechanisms underlying cancer and has the potential for increased utility with the advent of clinical …See details»
GitHub - genome/sciclone: An R package for inferring the …
SciClone: Inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. Christopher A. Miller 1*, Brian S. White 2*, Nathan D. Dees 1, ...See details»